Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 351-360 of 1760 for

Edit search filters
  1. Nivolumab And Brentuximab Vedotin In Treating Older Patients With Untreated Hodgkin Lymphoma

    Rochester, MN

  2. Nivolumab After Combined Modality Therapy In Treating Patients With High Risk Stage II-IIIB Anal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Ixazomib Citrate, Lenalidomide, Dexamethasone, And Daratumumab In Treating Patients With Newly Diagnosed Multiple Myeloma

    Rochester, MN

  4. A Study To Evaluate CTX110 In Subjects With Relapsed Or Refractory B-Cell Malignancies

    Jacksonville, FL

  5. A Study To Evaluate Lenalidomide And Dexamethasone, With Or Without Daratumumab, In Treating High-Risk Smoldering Myeloma Patients

    Albert Lea, MN, Eau Claire, WI, Rochester, MN

  6. A Study Of Atezolizumab Alone Or Combined With Immunomodulatory Drug And/or Daratumumab In Multiple Myeloma Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. Study Comparing Daratumumab, Lenalidomide, And Dexamethasone With Lenalidomide And Dexamethasone In Participants With Previously Untreated Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  8. Safety And Efficacy Of Bb2121 (Ide-cel) Combinations In Multiple Myeloma

    Jacksonville, FL

  9. Lenalidomide And Low-Dose Dexamethasone In Patients With Previously Treated Multiple Myeloma And Kidney Dysfunction

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study Of Belantamab Mafodotin (GSK2857916) In Multiple Myeloma Participants With Normal And Impaired Renal Function

    Jacksonville, FL

.

Mayo Clinic Footer